| 1 | Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats | 3.5 | 1 | Citations (PDF) |
| 2 | Diabetic Encephalopathy in a Preclinical Experimental Model of Type 1 Diabetes Mellitus: Observations in Adult Female Rat | 4.5 | 12 | Citations (PDF) |
| 3 | Neuroactive Steroid–Gut Microbiota Interaction in T2DM Diabetic Encephalopathy | 4.4 | 7 | Citations (PDF) |
| 4 | Allopregnanolone: An overview on its synthesis and effects | 3.7 | 86 | Citations (PDF) |
| 5 | Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin | 0.7 | 42 | Citations (PDF) |
| 6 | Gut Steroids and Microbiota: Effect of Gonadectomy and Sex | 4.4 | 20 | Citations (PDF) |
| 7 | Paroxetine effects in adult male rat colon: Focus on gut steroidogenesis and microbiota | 2.8 | 18 | Citations (PDF) |
| 8 | Identification of a novel off-target of paroxetine: Possible role in sexual dysfunction induced by this SSRI antidepressant drug | 4.2 | 9 | Citations (PDF) |
| 9 | Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of Allopregnanolone in Adult Male Rats | 4.4 | 10 | Citations (PDF) |
| 10 | Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target | 6.7 | 21 | Citations (PDF) |
| 11 | Effects of paroxetine treatment and its withdrawal on neurosteroidogenesis | 2.8 | 12 | Citations (PDF) |
| 12 | Exploring the Impact of the Microbiome on Neuroactive Steroid Levels in Germ-Free Animals | 4.5 | 23 | Citations (PDF) |
| 13 | Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role | 6.3 | 47 | Citations (PDF) |
| 14 | Post-finasteride syndrome: An emerging clinical problem | 3.5 | 72 | Citations (PDF) |
| 15 | Physiopathological Role of Neuroactive Steroids in the Peripheral Nervous System | 4.5 | 22 | Citations (PDF) |
| 16 | Sex dimorphism in an animal model of multiple sclerosis: Focus on pregnenolone synthesis | 2.4 | 7 | Citations (PDF) |
| 17 | Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites | 6.3 | 27 | Citations (PDF) |
| 18 | Neuroactive steroids, neurosteroidogenesis and sex | 6.0 | 95 | Citations (PDF) |
| 19 | Sex differences in the brain expression of steroidogenic molecules under basal conditions and after gonadectomy | 3.7 | 37 | Citations (PDF) |
| 20 | Treatment of male rats with finasteride, an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition | 2.8 | 61 | Citations (PDF) |
| 21 | Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin? | 2.7 | 62 | Citations (PDF) |
| 22 | Neuroactive steroids and diabetic complications in the nervous system | 6.3 | 30 | Citations (PDF) |
| 23 | Diabetes induces mitochondrial dysfunction and alters cholesterol homeostasis and neurosteroidogenesis in the rat cerebral cortex | 2.4 | 27 | Citations (PDF) |
| 24 | Axonal transport in a peripheral diabetic neuropathy model: sex-dimorphic features | 4.6 | 26 | Citations (PDF) |
| 25 | Neuroactive Steroids and Sex-Dimorphic Nervous Damage Induced by Diabetes Mellitus | 4.2 | 10 | Citations (PDF) |
| 26 | Diabetes alters myelin lipid profile in rat cerebral cortex: Protective effects of dihydroprogesterone | 2.4 | 29 | Citations (PDF) |
| 27 | Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients | 2.4 | 81 | Citations (PDF) |
| 28 | Sterol regulatory element binding protein‐1C knockout mice show altered neuroactive steroid levels in sciatic nerve | 3.9 | 7 | Citations (PDF) |
| 29 | Profiling Neuroactive Steroid Levels After Traumatic Brain Injury in Male Mice | 2.6 | 32 | Citations (PDF) |
| 30 | Neuroactive steroid levels in healthy and diseased states | 1.1 | 1 | Citations (PDF) |
| 31 | Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features | 7.1 | 86 | Citations (PDF) |
| 32 | The lipogenic regulator Sterol Regulatory Element Binding Factor-1c is required to maintain peripheral nerve structure and function | 1.5 | 0 | Citations (PDF) |
| 33 | Neuroactive steroids and the peripheral nervous system: An update | 2.0 | 50 | Citations (PDF) |
| 34 | Correlation of brain levels of progesterone and dehydroepiandrosterone with neurological recovery after traumatic brain injury in female mice | 2.8 | 49 | Citations (PDF) |
| 35 | New steps forward in the neuroactive steroid field | 2.4 | 36 | Citations (PDF) |
| 36 | Lack of Sterol Regulatory Element Binding Factor-1c Imposes Glial Fatty Acid Utilization Leading to Peripheral Neuropathy | 27.4 | 56 | Citations (PDF) |
| 37 | Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma | 2.4 | 76 | Citations (PDF) |
| 38 | Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients | 3.9 | 58 | Citations (PDF) |
| 39 | Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions | 6.0 | 119 | Citations (PDF) |
| 40 | Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy | 2.4 | 46 | Citations (PDF) |
| 41 | Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology | 0.5 | 95 | Citations (PDF) |
| 42 | Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain, spinal cord and peripheral nerve levels in male and female rats | 2.8 | 133 | Citations (PDF) |
| 43 | LXR and TSPO as new therapeutic targets to increase the levels of neuroactive steroids in the central nervous system of diabetic animals | 3.7 | 44 | Citations (PDF) |
| 44 | Gender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosis | 2.1 | 35 | Citations (PDF) |
| 45 | Multimodal Analysis in Acute and Chronic Experimental Autoimmune Encephalomyelitis | 3.0 | 17 | Citations (PDF) |
| 46 | Sex-dimorphic effects of dehydroepiandrosterone in diabetic neuropathy | 2.4 | 23 | Citations (PDF) |
| 47 | Sex differences in the manifestation of peripheral diabetic neuropathy in gonadectomized rats: A correlation with the levels of neuroactive steroids in the sciatic nerve | 4.1 | 28 | Citations (PDF) |
| 48 | Role of Neuroactive Steroids in the Peripheral Nervous System | 4.1 | 50 | Citations (PDF) |
| 49 | Sex‐dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis | 3.9 | 54 | Citations (PDF) |
| 50 | Activation of the Liver X Receptor Increases Neuroactive Steroid Levels and Protects from Diabetes-Induced Peripheral Neuropathy | 3.7 | 80 | Citations (PDF) |
| 51 | Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels | 3.7 | 54 | Citations (PDF) |
| 52 | Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats | 2.1 | 106 | Citations (PDF) |
| 53 | Neuroprotective effects of a ligand of translocator protein-18kDa (Ro5-4864) in experimental diabetic neuropathy | 2.4 | 83 | Citations (PDF) |
| 54 | Neuroactive steroids and peripheral neuropathy | 5.6 | 85 | Citations (PDF) |
| 55 | Evaluation of neuroactive steroid levels by liquid chromatography–tandem mass spectrometry in central and peripheral nervous system: Effect of diabetes | 3.7 | 94 | Citations (PDF) |
| 56 | Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury | 2.4 | 113 | Citations (PDF) |
| 57 | Neuroprotective effects of progesterone and its derivatives in acquired peripheral neuropathy | 6.3 | 0 | Citations (PDF) |
| 58 | Sexually dimorphic effect of progesterone and its reduced metabolites on the gene expression of myelin proteins in rat Schwann cells | 6.3 | 0 | Citations (PDF) |
